Daewoong Pharmaceutical’s Botulinum Toxin Product Nabota Sets New Sales Record in First Half of 2022
Daewoong Pharmaceutical’s Botulinum Toxin Product Nabota Breaks Sales Record in First Half of 2023 Daewoong Pharmaceutical announced a groundbreaking achievement as their botulinum toxin product, Nabota, achieved record-breaking sales in the first half of this year. With total sales amounting to 75.3 billion won from January to June, Nabota has emerged as the top-selling domestic […]
Daewoong Pharmaceutical’s Botulinum Toxin ‘Nabota’ Achieves Record-Breaking Sales Figures
Daewoong Pharmaceutical’s Botulinum Toxin Preparation ‘Nabota’ Achieves Record Sales in First Half of the Year Byline: [Journalist Name] Daewoong Pharmaceutical, led by CEO Seung-ho Jeon and Chang-jae Lee, has made significant strides in its botulinum toxin preparation ‘Nabota’. The company recently announced that its sales for the first half of this year have reached an […]
The Beauty and Benefits of Botulinum Toxin: Treating Neurological Diseases and Enhancing Appearance
Botulinum Toxin: More Than Just a Cosmetic Procedure Botulinum toxin, commonly known as ‘Botox’, is a substance derived from the bacterium Clostridium botulinum. While it is widely used for cosmetic purposes, it also boasts several applications in the treatment of neurological diseases, such as excessive sweating in the palms, soles, and armpits. However, it is […]
Hugel Enters Thailand’s HA Filler Market with Approval from Thai Food and Drug Administration
Hugel Enters Thailand’s Cosmetics Market with HA Filler Approval In a significant development, Hugel, a renowned Korean biopharmaceutical company, has obtained approval from the Thai Food and Drug Administration (TFDA) for its hyaluronic acid (HA) filler, Revolex (Revolaxㆍdomestic product name: The Chaeum). This milestone allows Hugel to make its foray into Thailand’s thriving HA filler […]
Nabota’s Partner Evolus Raises 2023 Sales Forecast to $195 Million
Nabota’s Partner Evolus Raises Sales Forecast to $195 Million in Q2 2023 In a recent announcement, Daewoong Pharmaceutical’s CEOs Jeon Seung-ho and Lee Chang-jae revealed that Evolus, a partner of Nabota, has released its second-quarter results for 2023. The company’s sales forecast has been raised to $195 million (approximately KRW 250 billion) after a strong […]
Challenges and Opportunities for Domestic Botulinum Toxin Manufacturers in the Growing Foreign Market
The Challenges Faced by Domestic Companies in the Foreign Market As domestic companies strive to expand into foreign markets, one crucial challenge they face is technology. Traditionally, these companies focused on increasing awareness of pricing, marketing and sales, as well as ensuring proper signage. However, there is now a growing realization that they must also […]
The Battle for Botulinum: Can Korean Companies Compete with Botox in the Global Market?
Korean companies producing botulinum toxin preparations are facing challenges in the domestic market. Issues such as argument stress and indirect export lawsuits have weakened their position. The question now is whether domestic companies can compete with Botox, a brand that generates 6 trillion won in global sales. Can they establish a strong presence in the […]
Daewoong Pharmaceutical’s Nabota Shows Long-Term Effect on Glabellar Wrinkles in Phase 2 Trial
Daewoong Pharmaceutical Announces Success of High-Dose Clinical Trial for Botulinum Toxin Daewoong Pharmaceutical, led by CEOs Jeon Seung-ho and Lee Chang-jae, has recently announced the completion of a successful high-dose phase 2 clinical trial for their botulinum toxin product, Nabota (known as Jubo in the US). The trial aimed to test the long-term effects of […]
AbbVie Enhances Presence in Market with Rebranding of ‘Botox’ as ‘AbbVie Botox’ after M&A with Allerganthetics
AbbVie and Allerganthetics Merge, ‘Botox’ Becomes ‘AbbVie Botox’ In a recent merger between AbbVie and Allerganthetics, the popular botulinum toxin product, ‘Botox’, has been rebranded as ‘AbbVie Botox’. AbbVie, a global pharmaceutical company, has infused its technology investment and support into the originality of Botox, signaling its plans to expand its presence in the market. […]
[보툴리눔톡신, 그것이 알고 싶다] ‘This’ should not be forgotten when popularizing botulinum toxin
Lee Seong-yong, director of Tonz Clinic Dongtan Branch Botulinum toxin is one of the most performed skin procedures worldwide and is the most loved regardless of age or gender. In Korea, more than 50% of those with experience in dermatology cosmetic procedures choose botulinum toxin as their first cosmetic procedure, so it can be said […]
